0.4274
price down icon15.38%   -0.0777
after-market Handel nachbörslich: .42 -0.0074 -1.73%
loading

Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.66%
33.43
35.07 34.08 44.04 37.93
Operating Expenses
9.49%
55.96
61.83 51.92 59.26 62.32
Operating Income/Loss
15.82%
-22.53
-26.76 -17.84 -15.22 -24.39
Nonoperating Income/Loss
1,118%
-44.50
4.369 -84.42 -17.87 -12.82
Income/Loss From Continuing Operations Before Tax
199.33%
-67.02
-22.39 -102.27 -33.09 -37.21
Income Tax Expense/Benefit
100.00%
-
0.001 -0.067 0.034 0.04
Net Income/Loss
199.32%
-67.02
-22.39 -102.20 -33.13 -37.25
Basic Average Shares
31.45%
0.0289
0.022 0.00235 0.00867 0.00862
Diluted Average Shares
17.09%
0.0289
0.0247 0.00235 0.00867 0.00862
Basic Earnings Per Share
127.45%
-2.32
-1.02 -7.00 -3.82 -4.32
Diluted Earnings Per Share
87.10%
-2.32
-1.24 -7.00 -3.82 -4.32
$10.31
price down icon 4.80%
$18.15
price down icon 7.82%
$3.32
price down icon 8.03%
$9.78
price down icon 10.36%
$7.02
price down icon 4.62%
$10.39
price down icon 8.22%
Kapitalisierung:     |  Volumen (24h):